Jinfei Yang

679 total citations
26 papers, 462 citations indexed

About

Jinfei Yang is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Jinfei Yang has authored 26 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Jinfei Yang's work include Autophagy in Disease and Therapy (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Jinfei Yang is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Jinfei Yang collaborates with scholars based in China. Jinfei Yang's co-authors include Ming Yang, Lin Sun, Chenrui Li, Shilu Luo, Yachun Han, Na Jiang, Hao Zhao, Ling Wei, Li Xiao and Ying Xiao and has published in prestigious journals such as Diabetes, Scientific Reports and The FASEB Journal.

In The Last Decade

Jinfei Yang

26 papers receiving 459 citations

Peers

Jinfei Yang

EPIDE

NEPHR

PHYSI

Shilu Luo China

Yanqing Chi China

Jun Feng China

Xing Mao China

Jili Zhu China

Carolina Victória Cruz Junho Brazil

Yachen Shen China

Hengdao Liu China

Thor Tejada United States

Zhengxian Zhang China

Shilu Luo China

Jinfei Yang

307 ×1.5

127 ×1.2

EPIDE

88 ×0.8

NEPHR

104 ×1.2

99 ×1.4

PHYSI

Citations per year, relative to Jinfei Yang Jinfei Yang (= 1×) peers Shilu Luo

Countries citing papers authored by Jinfei Yang

Since Specialization

Citations

This map shows the geographic impact of Jinfei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfei Yang more than expected).

Fields of papers citing papers by Jinfei Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfei Yang. The network helps show where Jinfei Yang may publish in the future.

Co-authorship network of co-authors of Jinfei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfei Yang. A scholar is included among the top collaborators of Jinfei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfei Yang. Jinfei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Junwei, Shu-Hui Wang, Meng Wang, & Jinfei Yang. (2025). Analysis of genes implicated in non-obstructive azoospermia. Steroids. 216. 109583–109583. 1 indexed citations

Zhao, Hao, Ming Yang, Yachun Han, et al.. (2024). HIF-1α/BNIP3-Mediated Endoplasmic Reticulum Degradation via Autophagy Protects Against Ischemia Reperfusion-Induced Acute Kidney Injury. Antioxidants and Redox Signaling. 42(4-6). 212–227. 3 indexed citations

Yang, Jinfei, Li Li, Chenrui Li, et al.. (2023). PACS-2 deficiency aggravates tubular injury in diabetic kidney disease by inhibiting ER-phagy. Cell Death and Disease. 14(10). 649–649. 9 indexed citations

Yang, Jinfei & Siying Li. (2023). Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology. Frontiers in Pharmacology. 14. 1118804–1118804. 6 indexed citations

Yang, Ming, Shilu Luo, Jinfei Yang, et al.. (2022). Myokines: Novel therapeutic targets for diabetic nephropathy. Frontiers in Endocrinology. 13. 1014581–1014581. 11 indexed citations

Liu, Chongbin, Ming Yang, Li Li, et al.. (2022). A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease. Frontiers in Physiology. 13. 909569–909569. 11 indexed citations

Yang, Ming, Shilu Luo, Jinfei Yang, et al.. (2022). Lipid droplet - mitochondria coupling: A novel lipid metabolism regulatory hub in diabetic nephropathy. Frontiers in Endocrinology. 13. 1017387–1017387. 25 indexed citations

Yang, Jinfei, Chenrui Li, Yan Liu, et al.. (2022). Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease. Frontiers in Pharmacology. 13. 832299–832299. 7 indexed citations

Yang, Ming, Shilu Luo, Jinfei Yang, et al.. (2022). Crosstalk between the liver and kidney in diabetic nephropathy. European Journal of Pharmacology. 931. 175219–175219. 6 indexed citations

10.

Li, Li, Chenrui Li, Chengyuan Tang, et al.. (2022). PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease. Molecular Medicine. 28(1). 117–117. 20 indexed citations

11.

Luo, Shilu, Jinfei Yang, Wei Chen, et al.. (2022). Bone-kidney axis: A potential therapeutic target for diabetic nephropathy. Frontiers in Endocrinology. 13. 996776–996776. 6 indexed citations

12.

Luo, Shilu, Ming Yang, Yachun Han, et al.. (2022). β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stress. International Immunopharmacology. 111. 109101–109101. 36 indexed citations

13.

Xiong, Xiaofen, Ling Wei, Ying Xiao, et al.. (2021). Effects of family history of diabetes on pancreatic β-cell function and diabetic ketoacidosis in newly diagnosed patients with type 2 diabetes: a cross-sectional study in China. BMJ Open. 11(1). e041072–e041072. 6 indexed citations

14.

Luo, Shilu, Ming Yang, Hao Zhao, et al.. (2021). Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease. Frontiers in Pharmacology. 12. 768100–768100. 24 indexed citations

15.

Yang, Ming, Shilu Luo, Xi Wang, et al.. (2021). ER-Phagy: A New Regulator of ER Homeostasis. Frontiers in Cell and Developmental Biology. 9. 684526–684526. 57 indexed citations

16.

Yang, Ming, Yachun Han, Shilu Luo, et al.. (2021). MAMs Protect Against Ectopic Fat Deposition and Lipid-Related Kidney Damage in DN Patients. Frontiers in Endocrinology. 12. 609580–609580. 32 indexed citations

17.

Zhao, Hao, Yachun Han, Na Jiang, et al.. (2021). Effects of HIF-1α on renal fibrosis in cisplatin-induced chronic kidney disease. Clinical Science. 135(10). 1273–1288. 29 indexed citations

18.

Yang, Ming, Chenrui Li, Shikun Yang, et al.. (2020). Mitophagy: A Novel Therapeutic Target for Treating DN. Current Medicinal Chemistry. 28(14). 2717–2728. 21 indexed citations

19.

Xiong, Xiaofen, Ling Wei, Ying Xiao, et al.. (2020). Family history of diabetes is associated with diabetic foot complications in type 2 diabetes. Scientific Reports. 10(1). 17056–17056. 14 indexed citations

20.

Yang, Jinfei, Ying Xiao, Ling Wei, et al.. (2020). The single nucleotide polymorphism rs11643718 in SLC12A3 is associated with the development of diabetic kidney disease in Chinese people with type 2 diabetes. Diabetic Medicine. 37(11). 1879–1889. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact